CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Diabetes type 2Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (6)

Name (Synonyms) Correlation
drug1341 Hypertension Wiki 1.00
drug3276 gammaCore® Sapphire (non-invasive vagus nerve stimulator) Wiki 1.00
drug2738 Statins (Cardiovascular Agents) Wiki 1.00
drug2711 Standard of care therapies Wiki 1.00
drug1943 Obesity Wiki 1.00
drug234 Antihypertensive Agents Wiki 1.00

Correlated MeSH Terms (7)

Name (Synonyms) Correlation
D012818 Signs and Symptoms, Respiratory NIH 0.50
D013577 Syndrome NIH 0.10
D055371 Acute Lung Injury NIH 0.10
D012127 Respiratory Distress Syndrome, Newborn NIH 0.09
D012128 Respiratory Distress Syndrome, Adult NIH 0.08
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Cardiovascular Disease, Cardiovascular Risk Factors, Treatments and Severe COVID-19 Outcomes. A Nationwide Registry-based Case-Control Study

In this study we cross-reference several nationwide high-quality Swedish registers in order to study risk factors for severe Covid-19 outcomes.

NCT04426084 COVID-19 Other: Hypertension Other: Diabetes type 2 Other: Obesity Drug: Antihypertensive Agents Drug: Statins (Cardiovascular Agents)

Primary Outcomes

Description: Admitted to ICU in Sweden with a main diagnosis of Covid-19 confirmed by laboratory testing (ICD 10: U07.1) and requring mechanical ventilation

Measure: Severe Covid-19

Time: 2020-03-01 to 2020-05-11

Description: Admitted to ICU in Sweden with a diagnosis of Covid-19 confirmed by laboratory testing (ICD 10: U07.1) and a bidiagnosis of pulmonary embolism (ICD10:I26)

Measure: Severe Covid-19 with pulmonary embolism

Time: 2020-03-01 to 2020-05-11

Secondary Outcomes

Description: Number of participants admitted to ICU in Sweden with a verified diagnosis of Covid-19 requring CRRT

Measure: CRRT(Continuous Renal Replacement Therapy)

Time: 2020-03-01 to 2020-05-11

Description: Number of participants admitted to ICU in Sweden with a verified diagnosis of Covid-19 requring ECMO

Measure: ECMO (Extracorporeal Membrane Oxygenation )

Time: 2020-03-01 to 2020-05-11

Description: Number of participants admitted to ICU in Sweden with a verified diagnosis of Covid-19 with death occurring in ICU after admission

Measure: ICU Mortality

Time: 2020-03-01 to 2020-05-11

No related HPO nodes (Using clinical trials)